iTeos Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)·WATERTOWN, MA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q2 2025	6/30/25	8/6/25	→
10-Q	Q1 2025	3/31/25	4/28/25	→
10-K	FY 2024	12/31/24	3/5/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
10-Q	Q1 2024	3/31/24	5/10/24	→
↓

Earnings Releases (8-K)

4 shown

Filed	Period
5/13/21	Q2 FY2021	→
3/24/21	Q1 FY2021	→
11/12/20	Q4 FY2020	→
9/1/20	Q3 FY2020	→

News (8-K)

29 shown

Filed	Type	Description
8/29/25	Delisting	Completion of Acquisition or Disposition of Assets	→
7/21/25	Exec Change	Entry into a Material Definitive Agreement	→
6/17/25	Vote	Submission of Matters to a Vote of Security Holders	→
6/5/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
5/28/25	Exec Change	Costs Associated with Exit or Disposal Activities	→
5/13/25	Reg FD	Termination of a Material Definitive Agreement	→
↓

Prospectuses & Registrations

22 shown

Filed	Form	Description
8/29/25	S-8 POS	S-8 POS	→
8/29/25	S-8 POS	S-8 POS	→
8/29/25	S-8 POS	S-8 POS	→
8/29/25	S-8 POS	S-8 POS	→
8/29/25	S-8 POS	S-8 POS	→
8/29/25	S-8 POS	S-8 POS	→
↓

Filing History(413 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Nov 14, 2025

0001104659-25-112461

—

12.0 KB

15-12G

Sep 8, 2025

0001140361-25-03429315-12G

—

12.3 KB

EFFECT

Sep 4, 2025

9999999995-25-002827

—

1.8 KB

SCHEDULE 13D/A

Sep 3, 2025

0001214659-25-013290

—

28.8 KB

Aug 29, 2025

0000950170-25-1122414

Aug 29, 2025

21.3 KB

Aug 29, 2025

0000950170-25-1122404

Aug 29, 2025

25.3 KB

Aug 29, 2025

0000950170-25-1122394

Aug 29, 2025

9.9 KB

Aug 29, 2025

0000950170-25-1122384

Aug 29, 2025

6.9 KB

Aug 29, 2025

0000950170-25-1122364

Aug 29, 2025

19.3 KB

Aug 29, 2025

0000950170-25-1122354

Aug 29, 2025

15.0 KB

Aug 29, 2025

0001193125-25-1928174

Aug 29, 2025

6.9 KB

Aug 29, 2025

0001193125-25-1928184

Aug 29, 2025

9.0 KB

S-8 POS

Aug 29, 2025

0001140361-25-033433S-8 POS

—

25.6 KB

S-8 POS

Aug 29, 2025

0001140361-25-033430S-8 POS

—

25.6 KB

S-8 POS

Aug 29, 2025

0001140361-25-033428S-8 POS

—

25.6 KB

S-8 POS

Aug 29, 2025

0001140361-25-033427S-8 POS

—

25.6 KB

S-8 POS

Aug 29, 2025

0001140361-25-033426S-8 POS

—

25.6 KB

S-8 POS

Aug 29, 2025

0001140361-25-033425S-8 POS

—

25.6 KB

POS AM

Aug 29, 2025

0001140361-25-033424POS AM

—

20.6 KB

25-NSE

Aug 29, 2025

0001354457-25-000857

—

3.0 KB

8-K

Aug 29, 2025

0001193125-25-1920318-K

Aug 29, 2025

445.4 KB

SC 14D9/A

Aug 29, 2025

0001193125-25-192007SC 14D9/A

—

17.4 KB

SC TO-T/A

Aug 29, 2025

0001140361-25-033301SC TO-T/A

—

175.0 KB

SC TO-T/A

Aug 15, 2025

0001140361-25-031525SC TO-T/A

—

614.9 KB

SCHEDULE 13G/A

Aug 14, 2025

0000921895-25-002283

—

19.6 KB

25 filings shown

Filed	Form	Description
6/5/25	DEFA14A	DEFA14A	→
4/24/25	DEFA14A	DEFA14A	→
4/24/25	DEF 14A	DEF 14A	→
4/25/24	DEFA14A	DEFA14A	→
4/25/24	DEF 14A	DEF 14A	→
4/27/23	DEFA14A	DEFA14A	→
↓

iTeos Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(413 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
9/8/25	15-12G	15-12G	→
9/4/25	EFFECT	EFFECT	→
9/3/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
8/29/25	POS AM	POS AM	→
8/29/25	25-NSE	25-NSE	→
↓